We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$82.5B
AUM Growth
+$5.26B
Cap. Flow
-$2.02B
Cap. Flow %
-2.45%
Top 10 Hldgs %
38.94%
Holding
962
New
129
Increased
342
Reduced
292
Closed
136

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$429M
2
ABNB icon
Airbnb
ABNB
+$235M
3
TMUS icon
T-Mobile US
TMUS
+$156M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$139M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$111M

Top Sells

Rank Stock Value
1
DE icon
Deere & Co
DE
+$488M
2
BMY icon
Bristol-Myers Squibb
BMY
+$222M
3
EXPD icon
Expeditors International
EXPD
+$191M
4
QCOM icon
Qualcomm
QCOM
+$187M
5
CERN
Cerner Corp
CERN
+$171M

Sector Composition

Rank Sector Weight
1 Technology 26.12%
2 Consumer Discretionary 15.99%
3 Communication Services 13.72%
4 Healthcare 12.84%
5 Industrials 11.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EEFT icon
251
Euronet Worldwide
EEFT
$2.7B
$26.9M 0.03%
198,900
+602
+0.3% +$87.7K
TTEK icon
252
Tetra Tech
TTEK
$9.07B
$26.9M 0.03%
1,102,785
+43,375
+4% +$1.09M
CASY icon
253
Casey's General Stores
CASY
$30.9B
$26.9M 0.03%
138,112
+5,413
+4% +$1.17M
PRFT
254
DELISTED
Perficient Inc
PRFT
$26.6M 0.03%
+330,743
New +$23.3M
ENSG icon
255
The Ensign Group
ENSG
$10.7B
$26.6M 0.03%
+306,451
New +$26.5M
ESE icon
256
ESCO Technologies
ESE
$7.92B
$26.4M 0.03%
281,635
+11,104
+4% +$1.12M
LKFN icon
257
Lakeland Financial Corp
LKFN
$1.53B
$26.4M 0.03%
+428,162
New +$27.4M
WEX icon
258
WEX
WEX
$6.31B
$26.4M 0.03%
136,076
+1,012
+0.7% +$207K
NBIX icon
259
Neurocrine Biosciences
NBIX
$16.6B
$25.6M 0.03%
262,824
+10,327
+4% +$990K
AZEK
260
DELISTED
The AZEK Co
AZEK
$25.4M 0.03%
598,690
+158,434
+36% +$7.1M
PPBI
261
DELISTED
Pacific Premier Bancorp
PPBI
$25.4M 0.03%
599,483
+23,657
+4% +$1.05M
DAVA icon
262
Endava
DAVA
$156M
$24.8M 0.03%
218,933
+8,632
+4% +$835K
ON icon
263
ON Semiconductor
ON
$31.6B
$24.7M 0.03%
645,256
+172,713
+37% +$6.78M
STRO icon
264
Sutro Biopharma
STRO
$421M
$24.7M 0.03%
132,801
-2,698
-2% -$528K
JAZZ icon
265
Jazz Pharmaceuticals
JAZZ
$16.7B
$24.6M 0.03%
138,386
+10,265
+8% +$1.78M
SUI icon
266
Sun Communities
SUI
$14.7B
$24.5M 0.03%
143,005
+11,357
+9% +$1.88M
BKLN icon
267
Invesco Senior Loan ETF
BKLN
$6.74B
$24.2M 0.03%
1,094,379
– –
EXP icon
268
Eagle Materials
EXP
$6.57B
$24.2M 0.03%
170,504
+37,697
+28% +$5.42M
PTGX icon
269
Protagonist Therapeutics
PTGX
$9.44B
$24.1M 0.03%
+536,920
New +$17.7M
IAA
270
DELISTED
IAA, Inc. Common Stock
IAA
$24.1M 0.03%
441,399
-2,196
-0.5% -$126K
SHYF
271
DELISTED
The Shyft Group
SHYF
$24.1M 0.03%
+643,154
New +$24.2M
LFUS icon
272
Littelfuse
LFUS
$11.6B
$24.1M 0.03%
94,411
-8,436
-8% -$2.2M
TFIN icon
273
Triumph Financial Inc
TFIN
$1.82B
$23.8M 0.03%
319,979
-8,680
-3% -$739K
XIFR
274
XPLR Infrastructure LP
XIFR
$1.08B
$23.6M 0.03%
309,342
-7,437
-2% -$532K
ASND icon
275
Ascendis Pharma A/S
ASND
$16.8B
$23.6M 0.03%
179,446
+6,862
+4% +$914K
9 10
11
12 13

Similar funds

CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Loomis, Sayles & Company's Q2 2021 Portfolio in Review

As of Q2 2021, Loomis, Sayles & Company held 962 positions worth $82.5B, up 6.8% from $77.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Loomis, Sayles & Company's Q2 2021 filing shows 129 new, 342 increased, 292 reduced and 136 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 946,065 shares worth $160M. The largest sale was Deere & Co, an estimated $488M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q2 2021 buy was Alnylam Pharmaceuticals: 946,065 shares worth $160M.
  • Loomis, Sayles & Company added most to Vertex Pharmaceuticals in Q2 2021, an estimated $429M increase.
  • Loomis, Sayles & Company's biggest Q2 2021 reduction was Deere & Co, cutting an estimated $488M.
  • Loomis, Sayles & Company fully exited Goosehead Insurance in Q2 2021, selling an estimated $66.6M.
  • Loomis, Sayles & Company's ten largest holdings make up 39% of its $82.5B portfolio in Q2 2021.
  • Loomis, Sayles & Company opened 129 new positions and closed 136 in Q2 2021.
  • Loomis, Sayles & Company's portfolio value rose 6.8% quarter-over-quarter to $82.5B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2021, filed 13 Aug 2021.